Immune-Mediated Damage and Repair

A03

Interplay between pro-inflammatory cytokines and chromatin-remodeling enzymes in the regulation of central nervous system demyelination and repair

Univ.-Prof. Dr. rer. nat. Ari Waisman
Institut für Molekulare Medizin
Mainz

Prof. Dr. rer. nat. Claire Jacob
Institut für Entwicklungsbiologie und Neurobiologie
Mainz

 

B05

Topological patterns of damage and compensation in chronic neuroinflammation

Prof. Dr. med. Sergiu Groppa
Klinik für Neurologie
Mainz

Prof. Dr.-Ing. Muthuraman Muthuraman
Klinik für Neurologie
Mainz

Univ.-Prof. Dr. med. Dr. rer. nat. Dr. h.c. Sven G. Meuth
Klinik für Neurologie
Düsseldorf

 

B06

The role of thr kallikrein-kinin system to functional and structural impairment if network activity in multiple sclerosis

Prof. Dr. rer. nat. Thomas Budde
Institut für Physiologie I
Münster

Dr. med. Kerstin Göbel
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

Univ.-Prof. Dr. med. Dr. rer. nat. Dr. h.c. Sven G. Meuth
Klinik für Neurologie
Düsseldorf

 

B07

Linking cholesterol metabolism in myeloid cells to remyelination in mice and humans

Univ.-Prof. Dr. med. Tanja Kuhlmann
Institut für Neuropathologie
Münster

Prof. Dr. med. Mikael Simons
Institut für Neuronale Zellbiologie
TU München

 

B09

Rebalancing cortical neuronal hyperactivity as a new treatment strategy in neuroinflammation

Dr. med. Erik Ellwardt
Klinik für Neurologie
Mainz

Univ.-Prof. Dr. med. Albrecht Stroh
Institut für Mikroskopische Anatomie und Neurobiologie
Mainz

 

B10

Molecular dissection of autoimmune lesion induction and resolution in the central nervous system

Univ.-Prof. Dr. med. Martin Kerschensteiner
Institut für Klinische Neuroimmunologie
LMU München

Priv.-Doz. Dr. rer. nat. Naoto Kawakami
Institut für Klinische Neuroimmunologie
LMU München

 

B12

Balancing glutamate and cation channel signaling in inflammatory neuronal injury

Prof. Dr. med. Stefan Bittner
Klinik für Neurologie
Mainz

 

B13

Disturbed iron metabolism in phagocytes as a driver of chronic inflammation – a model of MS progression?

Univ.-Prof. Dr. med. Mikael Simons
Institut für Neuronale Zellbiologie
TU München

Univ.-Prof. Dr. med. Martin Kerschensteiner
Institut für Klinische Neuroimmunologie
LMU München

 

B14

NfL and EGFL7 as biomarkers for neuroaxoonal damage and BBB-integrity in neuroinflammation: a translational approach

Dr. med. Timo Uphaus
Klinik für Neurologie
Mainz

Univ.-Prof. Dr. med. Frauke Zipp
Klinik für Neurologie, Forschungszentrum Immuntherapie
Mainz

News

Mon, 20/09/2021
Register now: 1st Symposium inflammation and imaging
When?: from November 2nd to November 4th 2021 Where?: Schloss (seat of the University Administration) Muenster Organizers: Co-operative Research Centres 1009, 1450, Transregio 128, and Clinical Research Unit 342 – together with Interdisciplinary Centre of Clinical Research (IZKF) and Excellence Cluster Cells in Motion (CiM) Registration is open now! More information: here...more
Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more